Medication safety of prescription in pregnant women with constipation
- At: 2016 FIP Congress in Buenos Aires (Argentina)
- Type: Poster
- By: HUANG, Shu Fen (Chi-Mei medical center, Pharmacy, Tainan, China Taiwan)
- Co-author(s): Shu Fen Huang:
The prevalence of constipation in pregnancy ranges from 11% to 44%. Common medications like lubricants, bulk-forming agents, osmotic laxatives, stimulant laxatives, stool softeners, and enemas and suppositories are not necessarily suitable for use in pregnant women. FDA categorized the risks of taking a drug or biological product during pregnancy.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.